Neuropsychological Assessment for Early Detection and Diagnosis of Dementia: Current Knowledge and New Insights.

Alzheimer’s disease cognitive decline dementia differential diagnosis early detection neuropsychological assessment

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
12 Jun 2024
Historique:
received: 15 05 2024
revised: 06 06 2024
accepted: 10 06 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

Dementia remains an underdiagnosed syndrome, and there is a need to improve the early detection of cognitive decline. This narrative review examines the role of neuropsychological assessment in the characterization of cognitive changes associated with dementia syndrome at different states. The first section describes the early indicators of cognitive decline and the major barriers to their identification. Further, the optimal cognitive screening conditions and the most widely accepted tests are described. The second section analyzes the main differences in cognitive performance between Alzheimer's disease and other subtypes of dementia. Finally, the current challenges of neuropsychological assessment in aging/dementia and future approaches are discussed. Essentially, we find that current research is beginning to uncover early cognitive changes that precede dementia, while continuing to improve and refine the differential diagnosis of neurodegenerative disorders that cause dementia. However, neuropsychology faces several barriers, including the cultural diversity of the populations, a limited implementation in public health systems, and the adaptation to technological advances. Nowadays, neuropsychological assessment plays a fundamental role in characterizing cognitive decline in the different stages of dementia, but more efforts are needed to develop harmonized procedures that facilitate its use in different clinical contexts and research protocols.

Identifiants

pubmed: 38929971
pii: jcm13123442
doi: 10.3390/jcm13123442
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Déclaration de conflit d'intérêts

Cristóbal Carnero declares the authorship of the screening instruments Eurotest and Phototest, both included in this manuscript. Both are free to use under the Creative Commons License and may be used on a personal and individual basis under specific conditions (CC BY-NC-ND 2.5). The rest of the authors declare no conflicts of interest.

Auteurs

Patricia Alzola (P)

Department of Basic Psychology, Psychobiology and Methodology of Behavioral Sciences, University of Salamanca, 37005 Salamanca, Spain.

Cristóbal Carnero (C)

Neurology Department, Granada University Hospital Complex, 18014 Granada, Spain.

Félix Bermejo-Pareja (F)

Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Institute of Health Carlos III, 28029 Madrid, Spain.
Institute of Research i+12, University Hospital "12 de Octubre", 28041 Madrid, Spain.

Gonzalo Sánchez-Benavides (G)

Barcelonabeta Brain Research Center, 08005 Barcelona, Spain.

Jordi Peña-Casanova (J)

'Hospital del Mar' Medical Research Institute, 08003 Barcelona, Spain.

Verónica Puertas-Martín (V)

Faculty of Education, International University of La Rioja, 26006 La Rioja, Spain.

Bernardino Fernández-Calvo (B)

Department of Psychology, University of Córdoba, 14071 Córdoba, Spain.

Israel Contador (I)

Department of Basic Psychology, Psychobiology and Methodology of Behavioral Sciences, University of Salamanca, 37005 Salamanca, Spain.

Classifications MeSH